Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease

References

• Roda G, Ng SC, Kotze PG, et al. Author Correction: Crohn’s disease. Nat Rev Dis Primers. 2020;6(1). doi:10.1038/s41572-020-0193-x
   Google Scholar
• Shah SC, Colombel JF, Sands BE, Narula N. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn’s disease. Aliment Pharm Ther. 2016;43(3):317–333. doi:10.1111/apt.13475
   PubMed Web of Science ®Google Scholar
• Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(8):1425–1433. doi:10.1097/MIB.0000000000001140
   PubMed Web of Science ®Google Scholar
• Mosli MH, Zou GY, Garg SK, et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(6):802–819. doi:10.1038/ajg.2015.120
   PubMed Web of Science ®Google Scholar
• Lin JF, Chen JM, Zuo JH, et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis. 2014;20(8):1407–1415. doi:10.1097/MIB.0000000000000057
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Singh S, Jairath V, Sandborn WJ, Dulai PS. US practice patterns and impact of monitoring for mucosal inflammation after biologic initiation in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(11):1828–1837. doi:10.1093/ibd/izz081
   PubMed Web of Science ®Google Scholar
• Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Hodgson HJ, Chadwick VS, Pepys MB. Differing acute phase responses in Crohn’s disease and ulcerative colitis. Gut. 1986;27(7):809–813. doi:10.1136/gut.27.7.809
   PubMed Web of Science ®Google Scholar
• Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev. 1989;10(3):308–316.
   PubMed Web of Science ®Google Scholar
• Biolo G, Toigo G, Ciocchi B, et al. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition. 1997;13(9 Suppl):52S–57S. doi:10.1016/S0899-9007(97)00206-2
   PubMed Web of Science ®Google Scholar
• Lambadiari V, Kadoglou NP, Stasinos V, et al. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol. 2014;13:121. doi:10.1186/s12933-014-0121-z
   PubMed Web of Science ®Google Scholar
• Ni M, Wei W, Feng Q, et al. Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis. Clin Exp Rheumatol. 2013;31(3):394–399.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Storr M, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol. 1995;102(1):217–223. doi:10.1111/j.1365-2249.1995.tb06659.x
   PubMed Web of Science ®Google Scholar
• Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant. 1998;13(6):1476–1483. doi:10.1093/ndt/13.6.1476
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(19 Suppl A):5A–36A. doi:10.1155/2005/269076
   PubMedGoogle Scholar
• Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–512. doi:10.1016/S0016-5107(04)01878-4
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, Bernstein LH. Plasma transthyretin as a biomarker of lean body mass and catabolic states. Adv Nutr. 2015;6(5):572–580. doi:10.3945/an.115.008508
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y, Van Den Schrieck HG, De Nayer P, De Visscher M. The role of retinol-binding protein in protein-calorie malnutrition. Metabolism. 1975;24(5):633–641. doi:10.1016/0026-0495(75)90143-2
   PubMed Web of Science ®Google Scholar
• Xu YH, Guo Z, Huang LY, et al. A nomogram for predicting the response to exclusive enteral nutrition in adult patients with isolated colonic Crohn’s disease. Ther Adv Gastroenter. 2019;12:175628481988130. doi:10.1177/1756284819881301
   Web of Science ®Google Scholar
• Wang JH, Xi HY, Zhang K, et al. Circulating C-reactive protein to prealbumin ratio and prealbumin to fibrinogen ratio are two promising inflammatory markers associated with disease activity in rheumatoid arthritis. Clin Lab. 2020;66(5):757–762. doi:10.7754/Clin.Lab.2019.190833
   Web of Science ®Google Scholar
• Luo Y, Xue Y, Yuan X, et al. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection. Int J Clin Pract. 2020;75(4):e13831. doi:10.1111/ijcp.13831
   PubMed Web of Science ®Google Scholar
• Jones J, Loftus EV, Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn’s disease. Clin Gastroenterol H. 2008;6(11):1218–1224. doi:10.1016/j.cgh.2008.06.010
   PubMed Web of Science ®Google Scholar
• Hyung SJ, Deroo S, Robinson CV. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex. Acs Chem Biol. 2010;5(12):1137–1146. doi:10.1021/cb100144v
   PubMed Web of Science ®Google Scholar
• Gubatan J, Chou ND, Nielsen OH, Moss AC. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50(11–12):1146–1158. doi:10.1111/apt.15506
   PubMed Web of Science ®Google Scholar
• Kaplan M, Yuksel M, Ates I, et al. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases? J Gastroen Hepatol. 2016;31(6):1120–1125.
   PubMed Web of Science ®Google Scholar
• Zhu F, Feng D, Zhang T, et al. Altered uric acid metabolism in isolated colonic Crohn’s disease but not ulcerative colitis. J Gastroenterol Hepatol. 2019;34(1):154–161. doi:10.1111/jgh.14356
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis. 2018;12(6):742–752. doi:10.1093/ecco-jcc/jjy025
   PubMed Web of Science ®Google Scholar
• Zabetian-Targhi F, Mahmoudi MJ, Rezaei N, Mahmoudi M. Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases. Adv Nutr. 2015;6(6):748–762. doi:10.3945/an.115.008292
   PubMed Web of Science ®Google Scholar
• Nguyen MVC, Baillet A, Romand X, et al. Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis. Joint Bone Spine. 2019;86(2):195–201. doi:10.1016/j.jbspin.2018.05.006
   PubMed Web of Science ®Google Scholar
• Ye LN, Lin ZW, Liu J, Cao CQ. Vitamin D deficiency is associated with endoscopic severity in patients with Crohn’s disease. Gastroent Res Pract. 2017;2017:1–5. doi:10.1155/2017/4869718
   Web of Science ®Google Scholar
• Cohen BL, Sachar DB. Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease. Brit Med J. 2017;357:j2505.
   PubMed Web of Science ®Google Scholar